XML 23 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Apr. 30, 2019
Jan. 31, 2019
Oct. 31, 2018
Jul. 31, 2018
Apr. 30, 2018
Jan. 31, 2018
Oct. 31, 2017
Jul. 31, 2017
Apr. 30, 2019
Apr. 30, 2018
Income Statement [Abstract]                    
Net sales $ 34,748 $ 32,372 $ 37,278 $ 42,152 $ 44,508 $ 38,190 $ 41,471 $ 33,881 $ 146,550 $ 158,050
Cost of products sold                 121,231 125,891
Gross profit 4,842 5,230 7,773 7,474 9,118 8,309 7,911 6,821 25,319 32,159
Operating expenses                 23,207 22,240
Operating earnings                 2,112 9,919
Other income (expenses), net                 389 (1)
Interest expense                 (367) (299)
Earnings before income taxes                 2,134 9,619
Income tax expense (benefit)                 446 4,161
Net earnings (1,197) 15 1,454 1,416 1,613 888 1,765 1,192 1,688 5,458
Less: net earnings attributable to the noncontrolling interest 73 37 40 9 57 35 41 44 159 177
Net earnings attributable to Kewaunee Scientific Corporation $ (1,270) $ (22) $ 1,414 $ 1,407 $ 1,556 $ 853 $ 1,724 $ 1,148 $ 1,529 $ 5,281
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders                    
Basic (in usd per share) $ (0.46) $ (0.01) $ 0.52 $ 0.51 $ 0.58 $ 0.31 $ 0.64 $ 0.42 $ 0.56 $ 1.94
Diluted (in usd per share) $ (0.46) $ (0.01) $ 0.51 $ 0.50 $ 0.56 $ 0.30 $ 0.62 $ 0.42 $ 0.55 $ 1.90
Weighted average number of common shares outstanding                    
Basic (in shares)                 2,742 2,720
Diluted (in shares)                 2,794 2,777